Team

Meet the team

Morgan Group lab photo

Principal Investigator


Lab photo 

Dr Rhys Morgan

Email: rhys.morgan@sussex.ac.uk

Phone: +44 (0)1273877861

Address: Office 3C19, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

Twitter page: @RhysMorganLab 

ORCID IDhttp://orcid.org/0000-0003-0429-6294

Dr. Morgan completed his BSc in Biomedical Science at the University of Portsmouth before completing a PhD in Experimental Haematology at Cardiff University. His thesis examined the role of a Wnt signalling protein (γ-catenin) in AML under the supervision of Professors Alan Burnett, Richard Darley and Alex Tonks. From here Rhys joined the School of Cellular & Molecular Medicine at the University of Bristol to pursue his interests in signal transduction and cancer biology. Under the supervision of Professors Christos Paraskeva and Ann Williams he undertook post-doctoral studies investigating the role of the stem cell marker LGR5 and Wnt/EGF signal transduction in colorectal cancer.

Whilst at Bristol, Rhys was awarded a prestigious Kay Kendall Leukaemia Fund (KKLF) Junior Fellowship in 2016 targeting Wnt/β-catenin signalling in AML which remains his primary research focus. In 2018 Rhys moved his fellowship to the School of Life Sciences at the University of Sussex to establish his own leukaemia research laboratory and is now a Senior Lecturer in Biomedical Science in the department of Biochemistry & Biomedicine.

 

Research Fellow


Megan Wagstaff PhD graduation

Dr Megan Wagstaff (maternity leave until June 2024)

Email: m.wagstaff@sussex.ac.uk 

Phone: +44 (0)1273873610 (Office) +44 (0)1273878683 (Lab) 

Address: Office 3C18A, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

Megan graduated with a first class honors in Biochemistry from the University of Essex. She joined the lab in October 2018 completing a PhD examining novel β-catenin protein interactions in acute myeloid leukaemia (AML) alongside teaching and outreach duties in the School of Life Sciences. Megan has now passed her viva and is a post-doc in the group continuing to investigate dysregulated Wnt/β-catenin signalling in AML where she has signfificant responsibilties in the day to day running of the lab and research/undergraduate student supervision.

Research Fellow


 Image of Dr Aaron Goff

Dr Aaron Goff

Email: a.goff@sussex.ac.uk 

Phone: +44 (0)1273873610 (Office) +44 (0)1273878683 (Lab) 

Address: Office 3C18A, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

Aaron graduated with a first-class honours in Biological Sciences from the University of Plymouth, followed by a Masters of Research specialising in microbiology from the University of Southampton. He completed a PhD in 2022 at the Brighton & Sussex Medical School characterising the physiology of in vivo Mycobacterium tuberculosis using a transcriptomics approach, for novel drug discovery. He joined the lab in January 2024 and is investigating β-catenin interactions with RNA binding proteins (RBP) and RNA with aim of designing new therapeutics for AML treatment.

PhD Student


Sam O PhD 

Mr Samuel Olaitan

Email: S.Olaitan@sussex.ac.uk 

Phone: +44 (0)1273872626 (Office) +44 (0)1273878683 (Lab) 

Address: Office 3C22, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

Samuel is a lecturer from Lagos State University who secured a TET (Tertiary Education Training) funded scholarship from the Nigerian government to study with us. He joined the lab in October 2020 and his thesis will examine Wnt signalling events at the cell membrane of myeloid leukaemia cells, with the ultimate aim of discovering new immunotherapeutic targets.  

PhD Student


Okan Sevim presenting research poster

Mr Okan Sevim

Email: os254@sussex.ac.uk 

Phone: +44 (0)1273872626 (Office) +44 (0)1273878683 (Lab) 

Address: Office 3C22, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

Okan is a Turkish Ministry of National Education sponsored PhD student who graduated from Cumhuriyet University with a first class major in Molecular Biology & Genetics and double first class major in Biochemistry. He recently completed the Cancer Cell Biology MSc from University of Sussex with Distinction where he undertook a research project in the Morgan group. He will join the lab in May 2021 and his thesis will examine the role of β-catenin in post-transcriptional gene expression and RBP networks in AML.  

PhD Student/Clinical Fellow


 Photo of Hyun Park

Dr Hyun Park

Email: h.park@bsms.ac.uk 

Phone: +44 (0)1273872626 (Office) +44 (0)1273878683 (Lab) 

Address: Office 3C22, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

Hyun is a clinician who has completed the Foundation Programme, and is currently working at the CIRU (Clinical Investigation and Research Unit) at the Royal Sussex County Hospital. Dr Park studied medicine at Imperial College London with an intercalated BSc in Medical Sciences with Haematology. To support his progression into Haematology specialist training Hyun is undertaking a jointly supervised PhD project between Prof Timothy Chevassut and Dr Rhys Morgan targeting novel β-catenin interactions in AML cells.

PhD Student/Haematology Registrar


Dr David Palmer in the lab

Dr David Palmer

Email: bsms9xy2@sussex.ac.uk

Phone: +44 (0)1273872626 (Office) +44 (0)1273878683 (Lab) 

Address: Office 3C22, JMS Building, University of Sussex, Falmer, Brighton, BN1 9QG

David is a haematology registrar who is currently in the KSS deanery and since 2023 has started a PhD alongside a research fellowship, at Brighton and Sussex Medical School. David completed his medical degree in 2014 at the University of Exeter and completed an intercalated BSc honours degree in developmental biology from King’s College London. He completed his medical training in London and he is a member of the Royal College of Physicians. In 2019 he was awarded a scholarship to study an MSc in Cancer Science at the University College London, for which he was awarded a distinction. His PhD project is supervised by Dr Rhys Morgan and Professor Timothy Chevassut and is focussing on molecular events downstream of RUNX1, a frequently mutated gene in acute myeloid leukaemia.